Sudeep Pharma Q1 FY27 Results (NSE: SUDEEPPHRM)

· Analysis by Alpha Inflection

Signal: Margin expansion

Sudeep Pharma Q1 FY27 key financials
MetricValueYoYQoQ
Revenue₹158.27 Cr26.7%-13.2%
EBIT₹56.36 CrN/A
Net profit₹40.59 Cr29.8%
EPS₹3.5926.4%
EBIT margin38.1%

P&L walk

Consolidated revenue rose 26.7% YoY but fell 13.2% QoQ; gross margin compressed 188bps YoY to 64.2%, while the reported EBITDA margin recovered to 38.1% and PAT grew 29.8% YoY, led mainly by pharmaceutical, food and nutrition.

View original filing

Research and educational content only. Not investment advice.